inhibit, KAD 1229, KAD1229, KAD-1229, KcsA, Mitiglinide, Mitiglinide Calcium, insulinotropic, Inhibitor, hypoglycaemic, diabetes, ATP-sensitive K+ channels, anti-diabetic, S-21403, S21403, S 21403, Potassium Channel, PotassiumChannel, type
Mitiglinide Calcium (KAD-1229) is a rapid-acting insulin secretagogue that functions by blocking ATP-sensitive potassium channels in pancreatic beta-cells. It is a valuable research tool for studying glucose homeostasis and insulin secretion mechanisms in both in vitro cellular assays and in vivo models of type 2 diabetes.
Molekulargewicht:
668.88
Reinheit:
99.83% (May vary between batches)
CAS Nummer:
[145525-41-3]
Formel:
(C19H24NO3)2Ca
Target-Kategorie:
Potassium Channel,ATPase
Anwendungsbeschreibung:
Solubility: DMSO:5 mg/mL (7.48 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten